Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Affidea Nu-med Center of Oncological Diagnostics is a leading provider of comprehensive cancer care and diagnostic services in Poland. The entity was established following the acquisition of NU-MED Grupa by Affidea, the largest European provider of diagnostic imaging, outpatient care, and radiotherapy services. The centers provide a full spectrum of oncological services, including high-precision radiotherapy, chemotherapy, and advanced diagnostic imaging such as PET-CT, MRI, and CT scans. Operating several high-tech facilities in cities like Elbląg and Tomaszów Mazowiecki, the organization emphasizes a multidisciplinary approach to patient treatment. The integration into the Affidea network allows the centers to leverage international clinical protocols and state-of-the-art medical technology to improve patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Affidea Nu-med Center of Oncological Diagnostics.